Cargando…

Sodium-glucose Cotransporter-2 Inhibitors and Euglycaemic Diabetic Ketoacidosis in the Perioperative Period: Case Report

The use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) has been steadily increasing over the past few years due to their efficacy in glycaemic control as well as added benefits of weight loss and reduction in cardiovascular mortality. SGLT2i are a class of oral hypoglycaemics that work by inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhaveri, Urmita, Vardesh, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716770/
https://www.ncbi.nlm.nih.gov/pubmed/31511817
http://dx.doi.org/10.7759/cureus.5455